Literature DB >> 30622775

HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?

Yinan Chen1, Aiping Chen2, Hailin Jiang3, Yuxuan Zhang4, Lin Zhu5, Chunyan Xia6, Hong Yu7.   

Abstract

BACKGROUND: Primary pulmonary lymphoma (PPL) mainly comprises mucosa-associated lymphoid tissue (MALT) lymphoma as well as other subtypes of lymphoma. Different phenotypes of PPL demonstrate various high-resolution computed tomography (HRCT) features. We aimed to evaluate the value of HRCT in the diagnosis and differential diagnosis of PPL, especially between MALT lymphoma and non-MALT lymphoma and the correlation between CT and pathological features.
METHODS: We performed a retrospective analysis on 72 patients with PPL confirmed by pathology between 2007 and 2016. We compared the CT characteristics and correlation with pathological findings between MALT lymphoma and non-MALT lymphoma groups.
RESULTS: All 72 patients with PPL were classified into two groups: low-grade MALT lymphoma (MALToma) (56/72) and high-grade non-MALT lymphoma (non-MALToma) (16/72). The latter group consisted of diffuse large B cell lymphoma (8/72), Hodgkin's lymphoma (3/72), T-cell lymphoma (4/72), and intravascular large B-cell lymphoma (1/72). A total of 168 lesions were analyzed, including 57 cases with multiple lesions and 15 cases with single lesion. The manifestation of four distribution patterns: nodular or mass-like involvement pattern, diffuse interstitial lung disease (DILD) pattern, pneumonia-like consolidative pattern and mixed pattern was not significantly different between MALToma and non-MALToma (all P>0.05). Signs of air bronchogram and CT angiogram occurred significantly more often in individuals with MALToma group than those with non-MALToma (75% vs. 25%, P=0.001; 64.3% vs. 12.5%, P<0.001; respectively). Conversely, the halo sign presented more often in non-MALToma than in MALToma patients (19% vs. 63.6%, P=0.02). In addition, the butterfly sign was only observed in four patients with MALToma.
CONCLUSIONS: HRCT imaging phenotypes were beneficial in the diagnosis of PPL. Solitary or multifocal nodules/masses and consolidation were the most common imaging patterns. The air bronchogram sign, CT angiogram sign, halo sign, and butterfly sign could be potential to help to differentiate MALToma from non-MALToma.

Entities:  

Keywords:  Pulmonary lymphoma; computed tomography (CT); diagnosis; mucosa-associated lymphoid tissue lymphoma (MALT lymphoma); pathology

Year:  2018        PMID: 30622775      PMCID: PMC6297407          DOI: 10.21037/jtd.2018.10.63

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  PULMONARY MALIGNANT LYMPHOMAS AND PSEUDOLYMPHOMAS: CLASSIFICATION, THERAPY, AND PROGNOSIS.

Authors:  S L SALTZSTEIN
Journal:  Cancer       Date:  1963-07       Impact factor: 6.860

Review 2.  Bronchus- and nasal-associated lymphoid tissues.

Authors:  John Bienenstock; Mark R McDermott
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

Review 3.  CT halo sign: the spectrum of pulmonary diseases.

Authors:  Y R Lee; Y W Choi; K J Lee; S C Jeon; C K Park; J-N Heo
Journal:  Br J Radiol       Date:  2005-09       Impact factor: 3.039

4.  Pulmonary MALT lymphoma: imaging findings in 24 cases.

Authors:  L J King; S P Padley; A C Wotherspoon; A G Nicholson
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

5.  Primary pulmonary lymphoma.

Authors:  Brian B Graham; Douglas J Mathisen; Eugene J Mark; Ronald W Takvorian
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

6.  Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type.

Authors:  P J Kurtin; J L Myers; H Adlakha; J G Strickler; C Lohse; V S Pankratz; D J Inwards
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

7.  B-cell lymphoma of bronchus-associated lymphoid tissue (BALT): CT features in 10 patients.

Authors:  D K Lee; J G Im; K S Lee; J S Lee; J B Seo; J M Goo; T S Kim; J W Lee
Journal:  J Comput Assist Tomogr       Date:  2000 Jan-Feb       Impact factor: 1.826

8.  Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations.

Authors:  M Wislez; J Cadranel; M Antoine; B Milleron; M Bazot; C Mayaud; M F Carette
Journal:  Eur Respir J       Date:  1999-08       Impact factor: 16.671

9.  Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients.

Authors:  Young A Bae; Kyung Soo Lee; Joungho Han; Young-Hyeh Ko; Byung-Tae Kim; Myung Jin Chung; Tae Sung Kim
Journal:  Chest       Date:  2007-12-10       Impact factor: 9.410

Review 10.  Primary pulmonary lymphoma.

Authors:  J Cadranel; M Wislez; M Antoine
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

View more
  10 in total

1.  Extranodal localization of non-Hodgkin's lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature.

Authors:  Giorgio Galoppini; Beatrice Maranini; Giovanni Ciancio; Melissa Padovan; Gian Luca Casoni; Francesco Cavazzini; Roberta Gafà; Giovanni Lanza; Marcello Govoni
Journal:  J Scleroderma Relat Disord       Date:  2022-04-10

2.  The characteristic computed tomography findings of pulmonary B-cell non-Hodgkin's lymphoma and their role in predicting patient survival.

Authors:  Yan Wang; Zhao-Cheng Pan; Lan Zhu; Yuan-Yuan Ma; Mu-Chen Zhang; Li Wang; Wei-Li Zhao; Fu-Hua Yan; Qi Song
Journal:  Quant Imaging Med Surg       Date:  2021-02

3.  Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis.

Authors:  Eri Iwami; Fumimaro Ito; Kotaro Sasahara; Aoi Kuroda; Tatsu Matsuzaki; Takahiro Nakajima; Daichi Abe; Kimihiro Matsumoto; Aya Sasaki; Keisuke Eguchi; Takeshi Terashima
Journal:  Intern Med       Date:  2019-10-17       Impact factor: 1.271

Review 4.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

5.  Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma.

Authors:  Huayu He; Fengwei Tan; Qi Xue; Lei Liu; Yue Peng; Guangyu Bai; Moyan Zhang; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

6.  Evaluation of HRCT for the Differential Diagnosis of Pneumonia-Like Consolidation Pattern of Pulmonary MALT Lymphoma from Lobar Pneumonia.

Authors:  Wenli Qiu; Haibin Chen; Jian Zhang; Ren Shuai; Huifeng Zhang; Kai Guo; Li Zhu; Zhongqiu Wang
Journal:  Cancer Manag Res       Date:  2021-10-12       Impact factor: 3.989

7.  Radiographic findings useful for diagnosis of primary chest wall lymphoma without preceding pleural disease: A case report.

Authors:  Masanori Tanaka; Daichi Fujimoto; Hiroaki Akamatsu; Hiromitsu Sumikawa; Nobuyuki Yamamoto
Journal:  Respirol Case Rep       Date:  2022-08-15

8.  Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.

Authors:  Ying Peng; Wanling Qi; Zhehuang Luo; Qingyun Zeng; Yujuan Huang; Yulu Wang; Amit Sharma; Ingo G H Schmidt-Wolf; Fengxiang Liao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

9.  Rapidly progressing primary pulmonary lymphoma masquerading as lung infectious disease: A case report and review of the literature.

Authors:  Jin-Hong Jiang; Chun-Lai Zhang; Qin-Li Wu; Yong-Hua Liu; Xiao-Qiu Wang; Xiao-Li Wang; Bing-Mu Fang
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

10.  A retrospective study on the clinical characteristics and radiological features of primary pulmonary lymphoma.

Authors:  Xiaodong Xie; Lei Zhang; Mengjie Wu; Zheng Kang; Hongwei Yan; Xiuming Zhang; Wenrong Shen; Min Dong
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.